Talking Precision Medicine

Tim Wahlberg | What would you (and your AI) do with the world’s largest curated chemistry data catalog? | TPM podcast #60

Artificial intelligence may be transforming drug discovery, but AI is only as powerful as the data it learns from. Behind many of today's scientific breakthroughs sits an

Jacob Hooker | From motifs to medicines: Harnessing nature’s pharmacopeia for novel CNS therapies | TPM podcast #59

Mental health remains one of medicine's greatest unmet needs. In this episode, Jacob Hooker explains how Sensorium Therapeutics is searching for new psychiatric medicines

James Zanewicz | Fostering innovation at scale: it’s all about the ecosystem | TPM podcast #58

In episode 58, Rafael sits down with James Zanewicz, CEO of Connect, to discuss the art and science of building innovation ecosystems. From Connect's origins as the world

Lisa Gurry | To Infinity and beyond: the future of comprehensive testing and genetic medicine | TPM podcast #57

In this episode, Rafael Rosengarten sits down with Lisa Gurry, Chief Business Officer at GeneDx, to discuss the transformative role of genomic testing in rare disease dia

Kamal Jethwani | The concierge CEO: Incubating the next generation of digital oncology companies | TPM podcast #56

In this episode, Rafael Rosengarten sits down with Dr. Kamal Jethwani, VP of Digital Ventures at Moffitt Cancer Center, CEO of AccelerOnc Studio, and consulting CEO of De

Shakti Ramkissoon | The Pulse of the Oncologist: Meeting clinicians and patients where they are to deliver precision medicine | TPM podcast #55

Precision oncology promises more data, more insight, and better decisions, yet in practice it often brings more complexity. In a new episode Rafael Rosengarten is joined

Sean Khozin | The rhythm and dissonance of cancer biology | TPM podcast #54

In this episode, Rafael Rosengarten speaks with Dr. Sean Khozin, CEO of the CEO Roundtable on Cancer. Sean shares how pre-competitive collaboration across industry, acade

Colette Delawalla | Be the change you want to see in the world: mobilizing to protect American science | TPM podcast #53

In this episode, I’m joined by Colette Delawalla, founder and CEO of Stand Up For Science. What began as frustration over a federal “banned words” list evolved into a nat

Ian Simon | When following the science isn’t enough: risk, communication, and the future of biotechnology | TPM podcast #52

In this episode, I’m joined by my longtime friend Ian Simon, Head of Biotechnology at Aspis Intelligence. Ian’s path runs from grad school vaccine research at Yale to sen

Michelle Chen | Using AI to derisk gene therapy and genetic medicine | TPM podcast #51

In this episode Rafael sits down with Michelle Chen, President and CEO of Form Bio, a techbio company using AI to advance genome engineering and the development of geneti

Mike Rossi, ConcertAI | Real world data and artificial intelligence turn anecdote to evidence | TPM podcast #50

Today I’m joined by Mike Rossi, Vice President of Translational Science and Multi-modal Real-World Evidence Solutions at ConcertAI. Mike has built a career at the interse

Mida Pezeshkian, Stema_cg | Launching products in healthcare: The most important framework is flexibility | TPM podcast #49

Joining us on this episode is Mida Pezeshkian, an old colleague and friend. Mida’s career has spanned from the depths of stem cell science as a student to her current foc

Michael Montalto, Amgen | How to have the biggest impact on patients: a career of invention, innovation, and implementation | TPM podcast #48

Today on the show, I’m joined by Michael Montalto, vice president of precision medicine at Amgen. Amgen is widely recognized as one of the most successful pharmaceutical

Tom Neyarapally, Archetype Therapeutics | A new paradigm for generative AI drug discovery: more accurate shots on a much wider goal | TPM podcast #47

Joining us on this episode is Tom Neyarapally, co-founder and CEO of Archetype Therapeutics, an exciting new AI-driven company in the drug discovery space. Archetype is a

Stéphane Budel, DeciBio | Precision medicine is our future and our fate | TPM podcast #46

Stéphane Budel, founding partner at DeciBio, joins the Talking Precision Medicine Podcast to explore the future of the field. He unpacks how liquid biopsy, multi-omics, a

Anna Berkenblit & Sudheer Doss, PanCAN | On a mission to beat an ignoble killer: pancreatic cancer | TPM podcast #45

Today’s guests are Anna Berkenblit, Chief Scientific and Medical Officer at the Pancreatic Cancer Action Network, and Sudheer Doss, Chief Business Officer at PanCAN. The

Najat Khan | Radical Transformation: Becoming a Medicines Company with End-to-End AI | TPM #44

Today’s guest is Najat Khan, Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals. Recursion is widely recognized as one of the most visible—and s

Ryan Fukushima | Reinventing diagnostics: The superpower of not knowing what can’t be done | TPM #43

What a pleasure to welcome today’s guest, Ryan Fukushima, chief operating officer of TempusAI. Not only has Ryan helped build Tempus brick by brick from the earliest days

The journey to the top of life sciences technology: a lifetime of listening and learning | Talking Precision Medicine #42

Today my guest is Joydeep Goswami, newly appointed President and CEO of the storied biotechnology company LGC. Joydeep is also a strategy advisor to Genialis. Join us as

The view from 30,000: Healthcare & life science AI in the cloud | Talking Precision Medicine #41

This episode features a conversation with Shweta Maniar, who leads the Healthcare and Life Science effort at Google cloud. In just a few short years, artificial intellige